These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12128085)

  • 1. Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides.
    Evin G; Weidemann A
    Peptides; 2002 Jul; 23(7):1285-97. PubMed ID: 12128085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
    Vassar R; Bennett BD; Babu-Khan S; Kahn S; Mendiaz EA; Denis P; Teplow DB; Ross S; Amarante P; Loeloff R; Luo Y; Fisher S; Fuller J; Edenson S; Lile J; Jarosinski MA; Biere AL; Curran E; Burgess T; Louis JC; Collins F; Treanor J; Rogers G; Citron M
    Science; 1999 Oct; 286(5440):735-41. PubMed ID: 10531052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
    Gandhi S; Refolo LM; Sambamurti K
    J Mol Neurosci; 2004; 24(1):137-43. PubMed ID: 15314262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human beta-secretase (BACE) and BACE inhibitors: progress report.
    John V
    Curr Top Med Chem; 2006; 6(6):569-78. PubMed ID: 16712492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for gamma-secretase and development of inhibitors.
    Tsai JY; Wolfe MS; Xia W
    Curr Med Chem; 2002 Jun; 9(11):1087-106. PubMed ID: 12052174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.
    Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS
    Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease.
    Wolfe MS; Xia W; Moore CL; Leatherwood DD; Ostaszewski B; Rahmati T; Donkor IO; Selkoe DJ
    Biochemistry; 1999 Apr; 38(15):4720-7. PubMed ID: 10200159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
    Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
    Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides.
    Zhang L; Song L; Terracina G; Liu Y; Pramanik B; Parker E
    Biochemistry; 2001 Apr; 40(16):5049-55. PubMed ID: 11305921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein.
    Sambamurti K; Sevlever D; Koothan T; Refolo LM; Pinnix I; Gandhi S; Onstead L; Younkin L; Prada CM; Yager D; Ohyagi Y; Eckman CB; Rosenberry TL; Younkin SG
    J Biol Chem; 1999 Sep; 274(38):26810-4. PubMed ID: 10480887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and Mkc7 proteases.
    Zhang W; Espinoza D; Hines V; Innis M; Mehta P; Miller DL
    Biochim Biophys Acta; 1997 Nov; 1359(2):110-22. PubMed ID: 9409808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Secretase inhibitors as molecular probes of presenilin function.
    Wolfe MS
    J Mol Neurosci; 2001 Oct; 17(2):199-204. PubMed ID: 11816793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
    Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
    J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid metabolism and secretases in Alzheimer's disease.
    Xia W
    Curr Neurol Neurosci Rep; 2001 Sep; 1(5):422-7. PubMed ID: 11898552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce Abeta in insect cells.
    Pitsi D; Kienlen-Campard P; Octave JN
    J Neurochem; 2002 Oct; 83(2):390-9. PubMed ID: 12423249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
    Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
    FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.